• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • Investors Relations
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
    • How to buy BIOMIMESYS®?
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Anti-Oxidant
      • Anti-Redness
      • Wound Healing
      • Skin Pigmentation
      • Anti-Pollution
      • Skin Microbiota
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications – Scientific articles
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificates of Analysis
    • TDS&MSDS
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us?
    • How to buy BIOMIMESYS®?
    • Subscribe to our Newsletter

toxicology

Biomimesys

Feedback to ESTIV2022 congress (European Society of Toxicology In Vitro)

The congress of European Society of Toxicology In Vitro (ESTIV) took place from 21st to 25th November 2022. This congress is focus on the alternative methods to animal testing, including both in silico and in vitro modeling. After a nice opening ceremony with a flamenco show, the scientific program begun Read more…

By Véronique De Conto, 6 monthsDecember 6, 2022 ago
Biomimesys

Summary from the founding congress of STCM last week

Last week we were pleased to attend the founding congress of STCM (Société de Toxicologie Cellularie et Moléculaire), which was held in FIAP Jean Monnet (Paris). The topic was “Toxicology towards the 3rd dimension“. With a wide variety of talks from academic laboratories and from the industry, the content was Read more…

By Elodie Vandenhaute, 4 yearsJune 18, 2019 ago
Biomimesys

Founding congress of STCM association in Paris this week

The founding congress of the french STCM (Société de Toxicologie Cellulaire et Moléculaire) will take place in Paris at the end of this week (13th-14th June, 2019). The theme of this meeting will be “Toxicology towards the 3rd dimension“. We are looking forward to attending this congress, and to becoming Read more…

By Elodie Vandenhaute, 4 yearsJune 11, 2019 ago
HCS, HCA & Biology

Revision of the guidance for the testing of cosmetic ingredients and their evaluation

On November 7th, the 10th revision of the SCCS’s Notes of Guidance has been released. If you work in cosmetology, you know the importance of this document used to “provide guidance to public authorities and to the cosmetic industry in order to improve harmonised compliance with the current cosmetic EU Read more…

By Pierre Jean Ferron, 4 yearsDecember 18, 2018 ago
News

Our feedback from ESTIV 2018

This year, the ESTIV (European Society of Toxicology In Vitro) congress took place in Berlin and was again a very interesting symposium. The plenary session was open by a presentation on 3D models made by bioengineering made by Paula Alves (Oireas/PT), and this year, a lot of presentations and poster were Read more…

By Pierre Jean Ferron, 5 yearsNovember 15, 2018 ago
News

Are you coming to Cosmetic 360 ?

Are your interested in meaning full images and high content analysis to asses your compounds properties ? Pierre-Jean, our dermocosmetic expert, will be present at Cosmetic 360 (the international trade fair for innovative ideas and solutions in the fragrance and cosmetics industry), 17th and 18th of October 2018 at Carrousel du Louvre in Read more…

By Pierre Jean Ferron, 5 yearsOctober 15, 2018 ago
News

See you soon in Berlin for ESTIV2018

The 20th International Congress on In Vitro Toxicology (ESTIV2018) is coming and it will be a great occasion for HCS-Pharma to showcase our current co-development, with the institute du thorax of Nantes and the RHU CHOPIN, on the use of hepatocyte-like cells differentiated from human induced pluripotent stem cells (hiPSC) Read more…

By Nathalie MAUBON, 5 yearsOctober 15, 2018 ago
HCS, HCA & Biology

Machine-learning software in toxicology : a step toward lab animal reduction

Every year around 10 millions of animals are used to assess compound’s safety, with a total cost estimated to 3 billions euro. Despite animal testing is mandatory by OECD to guarantee consumer safety, toxicologists are working on the development of alternative testing methods to solve this ethic and economic concern. Read more…

By Pierre Jean Ferron, 5 yearsAugust 21, 2018 ago
News

Last Day at Eurotox for Pierre-Jean

Many tremending studies presented this year !

By Pierre Jean Ferron, 6 yearsSeptember 13, 2017 ago
News

News from Pierre-Jean in EUROTOX 2017

The first keynote of professor Philip Steven was a passionated overview of neurosciences between non-human and human research

By Nathalie MAUBON, 6 yearsSeptember 11, 2017 ago
News

HCS Pharma at EUROTOX in September 10 and 13

See you in Bratislava for Eurotox 2017 ?

By Pierre Jean Ferron, 6 yearsSeptember 6, 2017 ago
HCS, HCA & Biology

How phenotypic screening could help to predict DILI ?

HCS/HCA is a great way to predict drugs toxicity

By Pierre Jean Ferron, 6 yearsMarch 16, 2017 ago
News

ESTIV2016 : a feedback

This year, the ESTIV (European Society of Toxicology In Vitro) congress took place at Juan-les-Pins, from October 17 to October 20, and was about In Vitro Toxicology for Human Safety

By Julian Bursztyka, 7 yearsNovember 4, 2016 ago
News

Welcome Pierre-Jean as new HCS Pharma study director !

We are very happy to present you Pierre-Jean Ferron, who joined HCS Pharma as a study director, specialized in cellular biology and high content analysis.

By Grégory MAUBON, 7 yearsJuly 7, 2016 ago
HCS, HCA & Biology

Webinar about HCA and HCS in toxicology testing by GEM

Genetic Engineering & Biotechnology News (GEN) organise a free webinar about HCS ans HCA use in drug toxicity and genotoxicity testing. High-content analysis (HCA) and high-content screening (HCS) enable imaging of large numbers of cellular samples for a variety of life science applications. Using automated high-resolution microscopy coupled with analytical Read more…

By Nathalie MAUBON, 9 yearsJune 10, 2014 ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • Development of devices to study brain and liver metastasis of triple negative breast cancer cells
  • Advantages of 3D Cell Culture in Immuno-Oncology
  • First week of business trip in Asia for Nathalie Maubon (HCS Pharma)
  • Feedback from Molecular Devices’ User Meeting in Copenhagen
  • Meet Nathalie in Boston during BIO International Convention!
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell Cell Culture congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix genotoxicity HCS hcs pharma High content screening hyaluronic acid imaging innovation in vitro in vitro models liver meeting Microbiota microenvironment microscopy Molecular Devices NEUROCELL3D neurotoxicity ONCO3D oncology organoids Parkinson phenotypic screening picture screening skin toxicology webinar
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress
 

Loading Comments...